![Nymox Pharmaceutical Corp](/common/images/company/N_NYMX.png)
Nymox Pharmaceutical Corp (NYMX)
NASDAQ
Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | -1.16 | -85.2941176471 | 1.36 | 2.27 | 0.1688 | 200808 | 0.86076992 | CS |
260 | -1.4 | -87.5 | 1.6 | 4.9 | 0.1688 | 199103 | 1.69099471 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.